Global Plerixafor Market Size, Status and Forecast 2024-2031

Report ID: 917520 | Published Date: Sep 2024 | No. of Page: 87 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Plerixafor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 24MG/1.2ML
        1.2.3 Type II
    1.3 Market by Application
        1.3.1 Global Plerixafor Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Non-Hodgkin's lymphoma (NHL) Patients
        1.3.3 Multiple myeloma (MM) Patients
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Plerixafor Market Perspective (2016-2027)
    2.2 Plerixafor Growth Trends by Regions
        2.2.1 Plerixafor Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Plerixafor Historic Market Share by Regions (2016-2021)
        2.2.3 Plerixafor Forecasted Market Size by Regions (2022-2027)
    2.3 Plerixafor Industry Dynamic
        2.3.1 Plerixafor Market Trends
        2.3.2 Plerixafor Market Drivers
        2.3.3 Plerixafor Market Challenges
        2.3.4 Plerixafor Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Plerixafor Players by Revenue
        3.1.1 Global Top Plerixafor Players by Revenue (2016-2021)
        3.1.2 Global Plerixafor Revenue Market Share by Players (2016-2021)
    3.2 Global Plerixafor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Plerixafor Revenue
    3.4 Global Plerixafor Market Concentration Ratio
        3.4.1 Global Plerixafor Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Plerixafor Revenue in 2020
    3.5 Plerixafor Key Players Head office and Area Served
    3.6 Key Players Plerixafor Product Solution and Service
    3.7 Date of Enter into Plerixafor Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Plerixafor Breakdown Data by Type
    4.1 Global Plerixafor Historic Market Size by Type (2016-2021)
    4.2 Global Plerixafor Forecasted Market Size by Type (2022-2027)

5 Plerixafor Breakdown Data by Application
    5.1 Global Plerixafor Historic Market Size by Application (2016-2021)
    5.2 Global Plerixafor Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Plerixafor Market Size (2016-2027)
    6.2 North America Plerixafor Market Size by Type
        6.2.1 North America Plerixafor Market Size by Type (2016-2021)
        6.2.2 North America Plerixafor Market Size by Type (2022-2027)
        6.2.3 North America Plerixafor Market Size by Type (2016-2027)
    6.3 North America Plerixafor Market Size by Application
        6.3.1 North America Plerixafor Market Size by Application (2016-2021)
        6.3.2 North America Plerixafor Market Size by Application (2022-2027)
        6.3.3 North America Plerixafor Market Size by Application (2016-2027)
    6.4 North America Plerixafor Market Size by Country
        6.4.1 North America Plerixafor Market Size by Country (2016-2021)
        6.4.2 North America Plerixafor Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Plerixafor Market Size (2016-2027)
    7.2 Europe Plerixafor Market Size by Type
        7.2.1 Europe Plerixafor Market Size by Type (2016-2021)
        7.2.2 Europe Plerixafor Market Size by Type (2022-2027)
        7.2.3 Europe Plerixafor Market Size by Type (2016-2027)
    7.3 Europe Plerixafor Market Size by Application
        7.3.1 Europe Plerixafor Market Size by Application (2016-2021)
        7.3.2 Europe Plerixafor Market Size by Application (2022-2027)
        7.3.3 Europe Plerixafor Market Size by Application (2016-2027)
    7.4 Europe Plerixafor Market Size by Country
        7.4.1 Europe Plerixafor Market Size by Country (2016-2021)
        7.4.2 Europe Plerixafor Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Plerixafor Market Size (2016-2027)
    8.2 Asia-Pacific Plerixafor Market Size by Type
        8.2.1 Asia-Pacific Plerixafor Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Plerixafor Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Plerixafor Market Size by Type (2016-2027)
    8.3 Asia-Pacific Plerixafor Market Size by Application
        8.3.1 Asia-Pacific Plerixafor Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Plerixafor Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Plerixafor Market Size by Application (2016-2027)
    8.4 Asia-Pacific Plerixafor Market Size by Region
        8.4.1 Asia-Pacific Plerixafor Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Plerixafor Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Plerixafor Market Size (2016-2027)
    9.2 Latin America Plerixafor Market Size by Type
        9.2.1 Latin America Plerixafor Market Size by Type (2016-2021)
        9.2.2 Latin America Plerixafor Market Size by Type (2022-2027)
        9.2.3 Latin America Plerixafor Market Size by Type (2016-2027)
    9.3 Latin America Plerixafor Market Size by Application
        9.3.1 Latin America Plerixafor Market Size by Application (2016-2021)
        9.3.2 Latin America Plerixafor Market Size by Application (2022-2027)
        9.3.3 Latin America Plerixafor Market Size by Application (2016-2027)
    9.4 Latin America Plerixafor Market Size by Country
        9.4.1 Latin America Plerixafor Market Size by Country (2016-2021)
        9.4.2 Latin America Plerixafor Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Plerixafor Market Size (2016-2027)
    10.2 Middle East & Africa Plerixafor Market Size by Type
        10.2.1 Middle East & Africa Plerixafor Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Plerixafor Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Plerixafor Market Size by Type (2016-2027)
    10.3 Middle East & Africa Plerixafor Market Size by Application
        10.3.1 Middle East & Africa Plerixafor Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Plerixafor Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Plerixafor Market Size by Application (2016-2027)
    10.4 Middle East & Africa Plerixafor Market Size by Country
        10.4.1 Middle East & Africa Plerixafor Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Plerixafor Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 sanofi-aventis
        11.1.1 sanofi-aventis Company Details
        11.1.2 sanofi-aventis Business Overview
        11.1.3 sanofi-aventis Plerixafor Introduction
        11.1.4 sanofi-aventis Revenue in Plerixafor Business (2016-2021)
        11.1.5 sanofi-aventis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Plerixafor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of 24MG/1.2ML
    Table 3. Key Players of Type II
    Table 4. Global Plerixafor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Plerixafor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Plerixafor Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Plerixafor Market Share by Regions (2016-2021)
    Table 8. Global Plerixafor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Plerixafor Market Share by Regions (2022-2027)
    Table 10. Plerixafor Market Trends
    Table 11. Plerixafor Market Drivers
    Table 12. Plerixafor Market Challenges
    Table 13. Plerixafor Market Restraints
    Table 14. Global Plerixafor Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Plerixafor Market Share by Players (2016-2021)
    Table 16. Global Top Plerixafor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plerixafor as of 2020)
    Table 17. Ranking of Global Top Plerixafor Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Plerixafor Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Plerixafor Product Solution and Service
    Table 21. Date of Enter into Plerixafor Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Plerixafor Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Plerixafor Revenue Market Share by Type (2016-2021)
    Table 25. Global Plerixafor Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Plerixafor Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Plerixafor Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Plerixafor Revenue Market Share by Application (2016-2021)
    Table 29. Global Plerixafor Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Plerixafor Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Plerixafor Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Plerixafor Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Plerixafor Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Plerixafor Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Plerixafor Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Plerixafor Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Plerixafor Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Plerixafor Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Plerixafor Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Plerixafor Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Plerixafor Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Plerixafor Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Plerixafor Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Plerixafor Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Plerixafor Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Plerixafor Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Plerixafor Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Plerixafor Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Plerixafor Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Plerixafor Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Plerixafor Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Plerixafor Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Plerixafor Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Plerixafor Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Plerixafor Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Plerixafor Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Plerixafor Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Plerixafor Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Plerixafor Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Plerixafor Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. sanofi-aventis Company Details
    Table 62. sanofi-aventis Business Overview
    Table 63. sanofi-aventis Plerixafor Product
    Table 64. sanofi-aventis Revenue in Plerixafor Business (2016-2021) & (US$ Million)
    Table 65. sanofi-aventis Recent Development
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Plerixafor Market Share by Type: 2020 VS 2027
    Figure 2. 24MG/1.2ML Features
    Figure 3. Type II Features
    Figure 4. Global Plerixafor Market Share by Application: 2020 VS 2027
    Figure 5. Non-Hodgkin's lymphoma (NHL) Patients Case Studies
    Figure 6. Multiple myeloma (MM) Patients Case Studies
    Figure 7. Plerixafor Report Years Considered
    Figure 8. Global Plerixafor Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 9. Global Plerixafor Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Plerixafor Market Share by Regions: 2020 VS 2027
    Figure 11. Global Plerixafor Market Share by Regions (2022-2027)
    Figure 12. Global Plerixafor Market Share by Players in 2020
    Figure 13. Global Top Plerixafor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plerixafor as of 2020
    Figure 14. The Top 10 and 5 Players Market Share by Plerixafor Revenue in 2020
    Figure 15. Global Plerixafor Revenue Market Share by Type (2016-2021)
    Figure 16. Global Plerixafor Revenue Market Share by Type (2022-2027)
    Figure 17. North America Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 18. North America Plerixafor Market Share by Type (2016-2027)
    Figure 19. North America Plerixafor Market Share by Application (2016-2027)
    Figure 20. North America Plerixafor Market Share by Country (2016-2027)
    Figure 21. United States Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. Canada Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Europe Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Plerixafor Market Share by Type (2016-2027)
    Figure 25. Europe Plerixafor Market Share by Application (2016-2027)
    Figure 26. Europe Plerixafor Market Share by Country (2016-2027)
    Figure 27. Germany Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. France Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. U.K. Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Italy Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Russia Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Nordic Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Plerixafor Market Share by Type (2016-2027)
    Figure 35. Asia-Pacific Plerixafor Market Share by Application (2016-2027)
    Figure 36. Asia-Pacific Plerixafor Market Share by Region (2016-2027)
    Figure 37. China Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Japan Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. South Korea Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Southeast Asia Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. India Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Australia Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Latin America Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Plerixafor Market Share by Type (2016-2027)
    Figure 45. Latin America Plerixafor Market Share by Application (2016-2027)
    Figure 46. Latin America Plerixafor Market Share by Country (2016-2027)
    Figure 47. Mexico Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Brazil Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Plerixafor Market Share by Type (2016-2027)
    Figure 51. Middle East & Africa Plerixafor Market Share by Application (2016-2027)
    Figure 52. Middle East & Africa Plerixafor Market Share by Country (2016-2027)
    Figure 53. Turkey Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Saudi Arabia Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. UAE Plerixafor Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. sanofi-aventis Revenue Growth Rate in Plerixafor Business (2016-2021)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
sanofi-aventis
Frequently Asked Questions
Plerixafor report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Plerixafor report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Plerixafor report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Romiplostim

Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates p ... Read More

Azelastine

Azelastine is a potent, second-generation, selective, histamine antagonist (histamine-H1-recep ... Read More